Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A germ cell tumor that arises from the ovary and occurs in children.
Biomarker and diagnostic research for pediatric ovarian germ cell tumor has been reported in the published literature.
7 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 5 PHASE2, 1 PHASE1, 1 NA. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06276491](https://clinicaltrials.gov/study/NCT06276491) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:18 AM UTC
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
PHASE1 |
Xencor, Inc. |
RECRUITING |
[NCT05500391](https://clinicaltrials.gov/study/NCT05500391) | Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring | PHASE2 | Centre Oscar Lambret | UNKNOWN |
[NCT02122185](https://clinicaltrials.gov/study/NCT02122185) | Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | PHASE2 | University of Chicago | UNKNOWN |
[NCT04876456](https://clinicaltrials.gov/study/NCT04876456) | A Phase II Trial of Cabozantinib With Patients With Refractory GCTs | PHASE2 | Jennifer King | ACTIVE_NOT_RECRUITING |
[NCT02834013](https://clinicaltrials.gov/study/NCT02834013) | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | PHASE2 | National Cancer Institute (NCI) | ACTIVE_NOT_RECRUITING |
48 publications have been identified in PubMed for pediatric ovarian germ cell tumor. Research spans Case Report / Case Series (52%), Review / Meta-Analysis (13%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 25 | 52% |
Research summaries | 6 | 13% |
Testing and diagnosis research | 5 | 10% |
Disease patterns and progression | 5 | 10% |
Laboratory research | 4 | 8% |
Other research | 2 | 4% |
New treatment approaches | 1 | 2% |
Nakashima M (2026). [PMID: 41292152](https://pubmed.ncbi.nlm.nih.gov/41292152/). *Cancer Sci*. [Basic Science / Preclinical]
Ali N (2026). [PMID: 41953206](https://pubmed.ncbi.nlm.nih.gov/41953206/). *J Cancer Allied Spec*. [Case Report / Case Series]
Rodríguez-Rubio Corona C (2026). [PMID: 41933956](https://pubmed.ncbi.nlm.nih.gov/41933956/). *Int J Gynecol Cancer*. [Case Report / Case Series]
Dey S (2026). [PMID: 42210622](https://pubmed.ncbi.nlm.nih.gov/42210622/). *Cancer Med*. [Epidemiology / Natural History]
Sood R (2026). [PMID: 42103533](https://pubmed.ncbi.nlm.nih.gov/42103533/). *J Am Soc Cytopathol*. [Diagnostic / Biomarker]
Abdelwahed A (2026). [PMID: 41739995](https://pubmed.ncbi.nlm.nih.gov/41739995/). *Adv Sci (Weinh)*. [Diagnostic / Biomarker]
Constantin MM (2026). [PMID: 41815478](https://pubmed.ncbi.nlm.nih.gov/41815478/). *Int J Surg Case Rep*. [Case Report / Case Series]
Bahall V (2026). [PMID: 41939179](https://pubmed.ncbi.nlm.nih.gov/41939179/). *Case Rep Womens Health*. [Case Report / Case Series]
Friedrich L (2025). [PMID: 38953909](https://pubmed.ncbi.nlm.nih.gov/38953909/). *Minerva Obstet Gynecol*. [Review / Meta-Analysis]
Addis NA (2025). [PMID: 40327914](https://pubmed.ncbi.nlm.nih.gov/40327914/). *Int J Surg Case Rep*. [Case Report / Case Series]